Moreover, this treatment protocol caused significant tumor growth delays and greatly prolonged survival times of the mice together with a significant decreased HIF1α/ABCG2 gene expression in tumors, when compared with the single drug treatments, suggesting the use of the combination schedule treatment. The gene discussed is ABCG2; the disease is neoplasm.